| 1 | [SID49822338] | Active | Potency | 4.6535 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Active | | Potency | 4.6535 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504834 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID49822338] | Active | Potency | 9.285 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504832, Type: confirmatory] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Active | | Potency | 9.285 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation | | AID | 504832 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID49822338] | Active | Potency | 12.5893 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 4 | [SID49822338] | Active | Potency | 12.5893 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 5 | [SID49822338] | Active | Potency | 12.5893 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 6 | [SID49822338] | Active | Potency | 12.5893 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 7 | [SID49822338] | Active | IC50 | 18.67 | A Cell Based Assay for the Identification of Lead Compounds with Inhibitory Activity against HIV-1 Fusion (CCR5 Tropic HIV-1 Fusion Inhibition Assay) - Dose Response [AID2279, Type: confirmatory] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Active | | IC50 | 18.67 [uM] | | BioAssay | A Cell Based Assay for the Identification of Lead Compounds with Inhibitory Activity against HIV-1 Fusion (CCR5 Tropic HIV-1 Fusion Inhibition Assay) - Dose Response | | AID | 2279 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID49822338] | Active | Potency | 28.1838 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Active | | Potency | 28.1838 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 9 | [SID49822338] | Active | Potency | 28.1838 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Active | | Potency | 28.1838 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 10 | [SID49822338] | Active | EC50 | 28.54 | A Cell Based Assay for the Identification of Lead Compounds with Inhibitory Activity against HIV-1 Fusion (CCR5 Tropic HIV-1 Fusion Inhibition Assay) - Cytotoxicity Counter Screen - Dose Response [AID2286, Type: confirmatory] | |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Active | | EC50 | 28.54 [uM] | | BioAssay | A Cell Based Assay for the Identification of Lead Compounds with Inhibitory Activity against HIV-1 Fusion (CCR5 Tropic HIV-1 Fusion Inhibition Assay) - Cytotoxicity Counter Screen - Dose Response | | AID | 2286 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 11 | [SID49822338] | Active | IC50 | 29.2 | uHTS fluorescence assay for the identification of Human Immunodeficiency Virus Fusion Inhibitors. [AID1986, Type: confirmatory] | envelope glycoprotein [Human immunodeficiency virus 1] [gi:45357394] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Active | | IC50 | 29.2 [uM] | | BioAssay | uHTS fluorescence assay for the identification of Human Immunodeficiency Virus Fusion Inhibitors. | | AID | 1986 | | BioAssay type | confirmatory | | Target | envelope glycoprotein [Human immunodeficiency virus 1] [gi:45357394] | | PubMed | | | Data Table |  |
|
| 12 | [SID49822338] | Active | Potency | 31.6228 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 13 | [SID49822338] | Active | Potency | 31.6228 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 14 | [SID49822338] | Active | Potency | 39.8107 | qHTS for Inhibitors of WRN Helicase [AID651768, Type: confirmatory] | WRN [Homo sapiens] [gi:3719421] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | qHTS for Inhibitors of WRN Helicase | | AID | 651768 | | BioAssay type | confirmatory | | Target | WRN [Homo sapiens] [gi:3719421] | | PubMed | | | Data Table |  |
|
| 15 | [SID49822338] | Active | Potency | 44.6684 | qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory] | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Active | | Potency | 44.6684 [uM] | | BioAssay | qHTS Assay for Inhibitors of BAZ2B | | AID | 504333 | | BioAssay type | confirmatory | | Target | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | | PubMed | | | Data Table |  |
|
| 16 | [SID49822338] | Active | Potency | 50.1187 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Active | | Potency | 50.1187 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 17 | [SID49822338] | Active | | | Counterscreen for molecules that bind rCAG RNA repeats: fluorescent based biochemical counterscreen assay for inhibitors of the DNA-based (5'CAG/3'GTC) TO-PRO-1 dye complex [AID652068, Type: screening] | |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Active | | BioAssay | Counterscreen for molecules that bind rCAG RNA repeats: fluorescent based biochemical counterscreen assay for inhibitors of the DNA-based (5'CAG/3'GTC) TO-PRO-1 dye complex | | AID | 652068 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 18 | [SID49822338] | Active | | | Single concentration counterscreen of uHTS hits for ATG4B inhibitors in a Phospholipase A2 assay [AID588402, Type: other] | phospholipase A2 precursor [Homo sapiens] [gi:4505847] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Active | | BioAssay | Single concentration counterscreen of uHTS hits for ATG4B inhibitors in a Phospholipase A2 assay | | AID | 588402 | | BioAssay type | other | | Target | phospholipase A2 precursor [Homo sapiens] [gi:4505847] | | PubMed | | | Data Table |  |
|
| 19 | [SID49822338] | Active | | | Single concentration counterscreen of uHTS hits for ATG4B inhibitors in a Phospholipase A2 assay [AID588402, Type: other] | phospholipase A2 precursor [Homo sapiens] [gi:4505847] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Active | | BioAssay | Single concentration counterscreen of uHTS hits for ATG4B inhibitors in a Phospholipase A2 assay | | AID | 588402 | | BioAssay type | other | | Target | phospholipase A2 precursor [Homo sapiens] [gi:4505847] | | PubMed | | | Data Table |  |
|
| 20 | [SID49822338] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1 [AID1672, Type: screening] | inward rectifier potassium channel 2 [Mus musculus] [gi:6680530] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1 | | AID | 1672 | | BioAssay type | screening | | Target | inward rectifier potassium channel 2 [Mus musculus] [gi:6680530] | | PubMed | | | Data Table |  |
|
| 21 | [SID49822338] | Active | | | Confirmatory screen for compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1 [AID2032, Type: screening] | inward rectifier potassium channel 2 [Mus musculus] [gi:6680530] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Active | | BioAssay | Confirmatory screen for compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1 | | AID | 2032 | | BioAssay type | screening | | Target | inward rectifier potassium channel 2 [Mus musculus] [gi:6680530] | | PubMed | | | Data Table |  |
|
| 22 | [SID49822338] | Active | | | uHTS fluorescent assay for identification of inhibitors of ATG4B [AID504462, Type: screening] | cysteine protease ATG4B isoform a [Homo sapiens] [gi:47132611] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Active | | BioAssay | uHTS fluorescent assay for identification of inhibitors of ATG4B | | AID | 504462 | | BioAssay type | screening | | Target | cysteine protease ATG4B isoform a [Homo sapiens] [gi:47132611] | | PubMed | | | Data Table |  |
|
| 23 | [SID49822338] | Active | | | Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling [AID588627, Type: screening] | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling | | AID | 588627 | | BioAssay type | screening | | Target | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] | | PubMed | | | Data Table |  |
|
| 24 | [SID49822338] | Active | | | Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling [AID588627, Type: screening] | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling | | AID | 588627 | | BioAssay type | screening | | Target | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] | | PubMed | | | Data Table |  |
|
| 25 | [SID49822338] | Active | | | Fluorescence-based biochemical high throughput confirmation assay to identify molecules that bind r(CAG) RNA repeats [AID652065, Type: screening] | |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical high throughput confirmation assay to identify molecules that bind r(CAG) RNA repeats | | AID | 652065 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 26 | [SID49822338] | Active | | | Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats [AID651821, Type: screening] | |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats | | AID | 651821 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 27 | [SID49822338] | Active | | | HTS Assay for Peg3 Promoter Inhibitors [AID588405, Type: screening] | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Active | | BioAssay | HTS Assay for Peg3 Promoter Inhibitors | | AID | 588405 | | BioAssay type | screening | | Target | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] | | PubMed | | | Data Table |  |
|
| 28 | [SID49822338] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 29 | [SID49822338] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 30 | [SID49822338] | Inactive | Potency | 6.3096 | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen [AID588856, Type: confirmatory] | |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Inactive | | Potency | 6.3096 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen | | AID | 588856 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 31 | [SID49822338] | Inactive | Potency | 35.4813 | qHTS of alpha-syn Inhibitors [AID652106, Type: confirmatory] | |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Inactive | | Potency | 35.4813 [uM] | | BioAssay | qHTS of alpha-syn Inhibitors | | AID | 652106 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 32 | [SID49822338] | Inactive | Potency | 35.4813 | qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide [AID1768, Type: confirmatory] | MEN1 gene product [Homo sapiens] [gi:18860839] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Inactive | | Potency | 35.4813 [uM] | | BioAssay | qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide | | AID | 1768 | | BioAssay type | confirmatory | | Target | MEN1 gene product [Homo sapiens] [gi:18860839] | | PubMed | | | Data Table |  |
|
| 33 | [SID49822338] | Inactive | Potency | 70.7946 | qHTS assay for re-activators of p53 using a Luc reporter [AID504706, Type: confirmatory] | P53 [Homo sapiens] [gi:23491729] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Inactive | | Potency | 70.7946 [uM] | | BioAssay | qHTS assay for re-activators of p53 using a Luc reporter | | AID | 504706 | | BioAssay type | confirmatory | | Target | P53 [Homo sapiens] [gi:23491729] | | PubMed | | | Data Table |  |
|
| 34 | [SID49822338] | Inactive | Potency | 70.7946 | qHTS assay for re-activators of p53 using a Luc reporter [AID504706, Type: confirmatory] | P53 [Homo sapiens] [gi:23491729] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Inactive | | Potency | 70.7946 [uM] | | BioAssay | qHTS assay for re-activators of p53 using a Luc reporter | | AID | 504706 | | BioAssay type | confirmatory | | Target | P53 [Homo sapiens] [gi:23491729] | | PubMed | | | Data Table |  |
|
| 35 | [SID49822338] | Inactive | Potency | 70.7946 | qHTS assay for re-activators of p53 using a Luc reporter [AID504706, Type: confirmatory] | P53 [Homo sapiens] [gi:23491729] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Inactive | | Potency | 70.7946 [uM] | | BioAssay | qHTS assay for re-activators of p53 using a Luc reporter | | AID | 504706 | | BioAssay type | confirmatory | | Target | P53 [Homo sapiens] [gi:23491729] | | PubMed | | | Data Table |  |
|
| 36 | [SID49822338] | Inactive | Potency | 70.7946 | qHTS assay for re-activators of p53 using a Luc reporter [AID504706, Type: confirmatory] | P53 [Homo sapiens] [gi:23491729] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Inactive | | Potency | 70.7946 [uM] | | BioAssay | qHTS assay for re-activators of p53 using a Luc reporter | | AID | 504706 | | BioAssay type | confirmatory | | Target | P53 [Homo sapiens] [gi:23491729] | | PubMed | | | Data Table |  |
|
| 37 | [SID49822338] | Inactive | | | qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Enhancers [AID493056, Type: screening] | thyrotropin-releasing hormone receptor [Homo sapiens] [gi:4507681] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Inactive | | BioAssay | qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Enhancers | | AID | 493056 | | BioAssay type | screening | | Target | thyrotropin-releasing hormone receptor [Homo sapiens] [gi:4507681] | | PubMed | | | Data Table |  |
|
| 38 | [SID49822338] | Inactive | | | qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Agonists. [AID493084, Type: screening] | thyrotropin-releasing hormone receptor [Homo sapiens] [gi:4507681] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Inactive | | BioAssay | qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Agonists. | | AID | 493084 | | BioAssay type | screening | | Target | thyrotropin-releasing hormone receptor [Homo sapiens] [gi:4507681] | | PubMed | | | Data Table |  |
|
| 39 | [SID49822338] | Inactive | Potency | | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101 [AID493005, Type: confirmatory] | TSG101 gene product [Homo sapiens] [gi:5454140] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101 | | AID | 493005 | | BioAssay type | confirmatory | | Target | TSG101 gene product [Homo sapiens] [gi:5454140] | | PubMed | | | Data Table |  |
|
| 40 | [SID49822338] | Inactive | Potency | | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101 [AID493005, Type: confirmatory] | TSG101 gene product [Homo sapiens] [gi:5454140] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101 | | AID | 493005 | | BioAssay type | confirmatory | | Target | TSG101 gene product [Homo sapiens] [gi:5454140] | | PubMed | | | Data Table |  |
|
| 41 | [SID49822338] | Inactive | | | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign [AID504810, Type: Literature] | TSHR protein [Homo sapiens] [gi:118341367] |   View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Inactive | | BioAssay | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | | AID | 504810 | | BioAssay type | Literature | | Target | TSHR protein [Homo sapiens] [gi:118341367] | | PubMed | 20427476 | | Data Table |  |
|
| 42 | [SID49822338] | Inactive | | | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign [AID504810, Type: Literature] | TSHR protein [Homo sapiens] [gi:118341367] |   View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Inactive | | BioAssay | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | | AID | 504810 | | BioAssay type | Literature | | Target | TSHR protein [Homo sapiens] [gi:118341367] | | PubMed | 20427476 | | Data Table |  |
|
| 43 | [SID49822338] | Inactive | | | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign [AID504810, Type: Literature] | TSHR protein [Homo sapiens] [gi:118341367] |   View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Inactive | | BioAssay | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | | AID | 504810 | | BioAssay type | Literature | | Target | TSHR protein [Homo sapiens] [gi:118341367] | | PubMed | 20427476 | | Data Table |  |
|
| 44 | [SID49822338] | Inactive | | | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign [AID504812, Type: Literature] | TSHR protein [Homo sapiens] [gi:118341367] |   View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Inactive | | BioAssay | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | | AID | 504812 | | BioAssay type | Literature | | Target | TSHR protein [Homo sapiens] [gi:118341367] | | PubMed | 20427476 | | Data Table |  |
|
| 45 | [SID49822338] | Inactive | | | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign [AID504812, Type: Literature] | TSHR protein [Homo sapiens] [gi:118341367] |   View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Inactive | | BioAssay | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | | AID | 504812 | | BioAssay type | Literature | | Target | TSHR protein [Homo sapiens] [gi:118341367] | | PubMed | 20427476 | | Data Table |  |
|
| 46 | [SID49822338] | Inactive | | | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign [AID504812, Type: Literature] | TSHR protein [Homo sapiens] [gi:118341367] |   View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Inactive | | BioAssay | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | | AID | 504812 | | BioAssay type | Literature | | Target | TSHR protein [Homo sapiens] [gi:118341367] | | PubMed | 20427476 | | Data Table |  |
|
| 47 | [SID49822338] | Inactive | IC50 | | uHTS HTRF assay for identification of inhibitors of SUMOylation [AID2006, Type: confirmatory] | SUMO-conjugating enzyme UBC9 [Homo sapiens] [gi:4507785] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | uHTS HTRF assay for identification of inhibitors of SUMOylation | | AID | 2006 | | BioAssay type | confirmatory | | Target | SUMO-conjugating enzyme UBC9 [Homo sapiens] [gi:4507785] | | PubMed | | | Data Table |  |
|
| 48 | [SID49822338] | Inactive | | | uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay [AID485273, Type: screening] | UBE2N gene product [Homo sapiens] [gi:4507793] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Inactive | | BioAssay | uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay | | AID | 485273 | | BioAssay type | screening | | Target | UBE2N gene product [Homo sapiens] [gi:4507793] | | PubMed | | | Data Table |  |
|
| 49 | [SID49822338] | Inactive | | | uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay [AID485273, Type: screening] | UBE2N gene product [Homo sapiens] [gi:4507793] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Inactive | | BioAssay | uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay | | AID | 485273 | | BioAssay type | screening | | Target | UBE2N gene product [Homo sapiens] [gi:4507793] | | PubMed | | | Data Table |  |
|
| 50 | [SID49822338] | Inactive | | | uHTS identification of SUMO1-mediated protein-protein interactions [AID602429, Type: screening] | SUMO-1 [Homo sapiens] [gi:1762973] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 49822338 | | CID | 24818332 | | Outcome | Inactive | | BioAssay | uHTS identification of SUMO1-mediated protein-protein interactions | | AID | 602429 | | BioAssay type | screening | | Target | SUMO-1 [Homo sapiens] [gi:1762973] | | PubMed | | | Data Table |  |
|